This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Zero Based Budgeting For Students Vs Professionals contrasts needs and priorities, offering budgeting approaches that fit student life or full-time careers.
16,296 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A major Taiwan chipmaker plans to double the size of its Arizona facility, a move Trump touts as a potential steeplec...
Energy markets moved on geopolitical headlines, lifting ConocoPhillips stock in intraday trading. This article explai...
Bloom Energy faces a bearish price prediction as momentum cools and AI-driven demand faces headwinds, suggesting sign...
Thor Industries reports a dramatic EPS surprise for Q2, with revenue rising modestly. Yet cash flow weakness and unev...
XRP’s derivatives market shows a rare drop in open interest while large holders accumulate on-chain. The move could h...
Target just reported 13th quarter slump, prompting questions about management, costs, and the path to growth. Here ar...
Thinking about sell micron stock? final. This guide breaks down the drivers behind MU, risk factors, and a clear verd...
This in-depth analysis digs into the drivers behind foods (bgs) 2025 earnings, exploring brand momentum, debt, and th...
Venice AI closes a $65 million Series A led by Dragonfly at a $1 billion valuation, funding growth with equity. The m...
Institutions are back in force for Bitcoin, led by US Bitcoin ETFs and MicroStrategy buying. Flows total about $1.25B...